| 000 | 01781 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517085058.0 | ||
| 264 | 0 | _c20180125 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1600-0625 | ||
| 024 | 7 |
_a10.1111/exd.13014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhao, Jingling | |
| 245 | 0 | 0 |
_aProstaglandin E2 inhibits collagen synthesis in dermal fibroblasts and prevents hypertrophic scar formation in vivo. _h[electronic resource] |
| 260 |
_bExperimental dermatology _c08 2016 |
||
| 300 |
_a604-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAzetidines |
| 650 | 0 | 4 |
_aCicatrix _xprevention & control |
| 650 | 0 | 4 | _aColforsin |
| 650 | 0 | 4 |
_aCollagen _xbiosynthesis |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xmetabolism |
| 650 | 0 | 4 |
_aDinoprostone _xmetabolism |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIsoindoles |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xmetabolism |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xmetabolism |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSmad Proteins _xmetabolism |
| 650 | 0 | 4 | _aSulfonamides |
| 650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism |
| 650 | 0 | 4 | _aTransforming Growth Factor beta1 |
| 700 | 1 | _aShu, Bin | |
| 700 | 1 | _aChen, Lei | |
| 700 | 1 | _aTang, Jinming | |
| 700 | 1 | _aZhang, Lijun | |
| 700 | 1 | _aXie, Julin | |
| 700 | 1 | _aLiu, Xusheng | |
| 700 | 1 | _aXu, Yingbin | |
| 700 | 1 | _aQi, Shaohai | |
| 773 | 0 |
_tExperimental dermatology _gvol. 25 _gno. 8 _gp. 604-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/exd.13014 _zAvailable from publisher's website |
| 999 |
_c25847236 _d25847236 |
||